-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Inozyme Pharma, Inc. annual/quarterly Operating Lease, Payments history and growth rate for Q1 2021.
- Inozyme Pharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2021 was $200K.
- Inozyme Pharma, Inc. annual Operating Lease, Payments for 2022 was $900K, unchanged from 2021.
- Inozyme Pharma, Inc. annual Operating Lease, Payments for 2021 was $900K, a 50% increase from 2020.
Operating Lease, Payments, Quarterly (USD)